Another study suggested that anti-CD40 treatment increased the level of antiapoptotic protein Bcl-x(L) in splenic B and T cells as well as in thymic T cells, provided nearly complete protection against sepsis-induced lymphocyte apoptosis, and improved the prognosis of sepsis [11]. This evidence concerns the gene BCL2L1 and Sepsis.